Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Resonance SpecialtiesBOM:524218 -0.29%70 Return-on-Tangible-Equity is 25.40% as of Mar. 2026, which is 111% above its 10-year median of 12.03. GuruFocus rates BOM:524218 with a GF Score™ of 70/100 and a GF Value™ of ₹141.58 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,572 Chemicals companies, Resonance Specialties ranks better than 82.57% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Resonance Specialties's annualized net income for the quarter that ended in Mar. 2026 was ₹183.8 Mil. Resonance Specialties's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹723.6 Mil. Therefore, Resonance Specialties's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 25.40%.
The historical rank and industry rank for Resonance Specialties's Return-on-Tangible-Equity or its related term are showing as below:
BOM:524218'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -3.31 Med: 12.03 Max: 29.79
Current: 15.55
During the past 13 years, Resonance Specialties's highest Return-on-Tangible-Equity was 29.79%. The lowest was -3.31%. And the median was 12.03%.
BOM:524218's Return-on-Tangible-Equity is ranked better than 82.57% of 1572
companies
in the Chemicals industry
Industry Median: 5.925
vs BOM:524218: 15.55
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Resonance Specialties Return-on-Tangible-Equity Related Terms
Resonance Specialties Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Resonance Specialties's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524218 vs DOW: Return-on-Tangible-Equity Comparison
For the Chemicals subindustry, Resonance Specialties's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Specialties Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Resonance Specialties's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Resonance Specialties's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 25.40% mean?
Resonance Specialties (BOM:524218) has a Return-on-Tangible-Equity of 25.40% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Resonance Specialties and its competitors. This is 111% above median its historical median of 12.03. According to the industry distribution chart, Resonance Specialties ranks #274 out of 1572 companies in the Chemicals industry, placing it in the top 17.4%.
Is Resonance Specialties' Return-on-Tangible-Equity too high?
Resonance Specialties' current Return-on-Tangible-Equity of 25.40% is 111% above median its 10-year median of 12.03. The Chemicals industry median Return-on-Tangible-Equity is 5.93. Resonance Specialties' value of 25.40% is 328.7% above this industry median. Based on the distribution chart, Resonance Specialties ranks #274 out of 1572 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Resonance Specialties has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Resonance Specialties' Return-on-Tangible-Equity compare to DOW?
According to the Chemicals industry distribution chart, Resonance Specialties ranks #274 out of 1572 companies for Return-on-Tangible-Equity. This places Resonance Specialties in the top 17% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 5.93. Resonance Specialties' value of 25.40% is 328.7% above this benchmark. While the company's 10-year median is 12.03 vs. the industry median of 5.93, Resonance Specialties has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 5.93, based on 1,572 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonance Specialties's current Return-on-Tangible-Equity of 25.40% is 328.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Resonance Specialties and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 5.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Specialties's current Return-on-Tangible-Equity is 25.40%, which is 111% above median its own 10-year median of 12.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Specialties stock overvalued right now?
Based on GuruFocus' analysis, Resonance Specialties (BOM:524218) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹141.58, compared to a current price of ₹169.65 — trading 19.8% above its estimated fair value. The current Return-on-Tangible-Equity is 25.40%, which is 111% above median its 10-year median of 12.03 and 328.7% above the Chemicals industry median of 5.93. Resonance Specialties' overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Resonance Specialties (BOM:524218), the current Return-on-Tangible-Equity is 25.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Resonance Specialties (BOM:524218) Overvalued in 2026?
Based on GuruFocus' analysis, Resonance Specialties stock appears to be overvalued.
The current stock price of ₹169.65 is trading 19.8% above its estimated GF Value™ of ₹141.58.
GuruFocus considers Resonance Specialties to be Modestly Overvalued.
Key valuation signals for BOM:524218:
Return-on-Tangible-Equity: 25.40% (111% above median its 10-year median of 12.03)
GF Value™: ₹141.58 vs. price of ₹169.65 (19.8% above fair value)
Industry Position: 328.7% above the Chemicals median (#274 of 1572)
No single metric tells the full story. See the BOM:524218 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Resonance Specialties Ltd is engaged in the manufacturing of chemicals. The company is manufacturing Pyridine, Picoline, Cynopyridine, and derivatives of the same. Bulk drugs and nutritional products are tolls converted. It delivers pyridine and related products. The company has only one segment which is Chemical Manufacturing. The company also manufactures anti-tuberculosis products such as Isoniazid. Geographically. It operates in India and Outside India. The majority of segment revenue is from Outside India.
70GF Score
Get the complete analysis for BOM:524218
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524218 has been successfully added to your 
